1. Home
  2. EXAS vs HUM Comparison

EXAS vs HUM Comparison

Compare EXAS & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

N/A

Current Price

$103.31

Market Cap

19.7B

Sector

Health Care

ML Signal

N/A

Logo Humana Inc.

HUM

Humana Inc.

N/A

Current Price

$165.45

Market Cap

22.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EXAS
HUM
Founded
1995
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
22.5B
IPO Year
2000
2002

Fundamental Metrics

Financial Performance
Metric
EXAS
HUM
Price
$103.31
$165.45
Analyst Decision
Hold
Hold
Analyst Count
17
20
Target Price
$86.62
$241.60
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
2.07%
EPS Growth
80.32
N/A
EPS
N/A
9.84
Revenue
$4,144,000.00
$129,664,000,000.00
Revenue This Year
$15.37
$24.46
Revenue Next Year
$12.41
$6.58
P/E Ratio
N/A
$17.36
Revenue Growth
N/A
10.11
52 Week Low
$38.88
$169.61
52 Week High
$104.02
$315.35

Technical Indicators

Market Signals
Indicator
EXAS
HUM
Relative Strength Index (RSI) 54.45 29.31
Support Level $102.95 N/A
Resistance Level $103.77 $192.01
Average True Range (ATR) 0.31 6.02
MACD -0.09 0.80
Stochastic Oscillator 33.18 1.96

Price Performance

Historical Comparison
EXAS
HUM

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Share on Social Networks: